IA2030 Scorecard
—Global
Type to select a Country
Antigen | Baseline (2019) | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
DTP3 | 69% | 65% | 66% | 68% | 68% |
MCV1 | 67% | 63% | 64% | 68% | 69% |
MCV2 | 56% | 54% | 56% | 59% | 61% |
The metadata for this indicator can be viewed here. The metadata typically includes the indicator's definitions, method of estimation, limitations, and sources.